The discovery that MPP+ could reliably and irreversibly induce Parkinson's disease in mammals reignited interest in Parkinson's research, which had previously been dormant for decades.[7] Following the revelation, MPP+ and MPTP sold out in virtually all chemical catalogs, reappearing months later with a 100-fold price increase.[7]